Calyxt (CLXT) Osake Kurssi
Calyxt Kurssi
Calyxtn liikevaihto on supistunut 25,8 % vuodessa viimeisten 7 vuoden aikana 157 000,00 USD:een. Calyxtn nettomarginaali −6 243,9 % on noussut verrattuna −11 820,8 %:iin muutama vuosi sitten. 8 analyytikosta 0 suosittaa ostoa — kokonaiskonsensus on Pidä.
Calyxt osakekurssi
Calyxt liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Calyxt -osakkeesta
Calyxt Inc's business model revolves around utilizing gene editing technology to develop healthier and more sustainable products. As a leading agricultural biotechnology company, Calyxt focuses on creating gene-edited crops with improved traits, such as enhanced nutrition, and reduced chemical inputs. By leveraging cutting-edge technologies like TALEN® and CRISPR/Cas9, Calyxt aims to address global challenges in the agriculture and food industry. With a commitment to environmental stewardship and consumer wellness, Calyxt Inc strives to revolutionize agricultural practices and contribute to a more sustainable future.
Calyxt Inc is primarily active in the agricultural industry, specializing in the development and commercialization of high-value crops through gene editing technology. With a focus on producing healthier, sustainable food ingredients, Calyxt Inc operates in sectors such as plant-based proteins, oils, and specialty food ingredients. Through their innovative gene-editing techniques, the company aims to improve crop traits, enhance nutritional value, and reduce environmental impact in the agricultural sector. Calyxt Inc's commitment to revolutionizing the food industry sets them apart as a leading player in developing healthier and more sustainable agricultural solutions.
The main competitors of Calyxt Inc in the market include companies such as Cibus, DuPont Pioneer, and Benson Hill Biosystems.
Calyxt Inc is a company with a rich history and background. Founded in 2010, Calyxt is a leading agricultural biotechnology company that focuses on developing healthier food products. With a mission to deliver high-value traits and healthier foods using cutting-edge gene-editing technologies, Calyxt has revolutionized the industry. Their expertise lies in using TALEN® technology to create gene-edited plants that enhance nutrition, reduce allergenicity, and improve crop quality. By working closely with farmers, food suppliers, and consumers, Calyxt aims to create sustainable and nutritious food solutions for a better future. Calyxt Inc continues to make significant strides in the field of agriculture and biotechnology.
Calyxt Inc, a leading biotechnology company, has achieved several significant milestones. First and foremost, the company successfully developed and commercialized high-value plant products using TALEN® gene-editing technology. This breakthrough technology enables precise modifications in plant genomes, resulting in improved crop traits and enhanced yields. Additionally, Calyxt Inc received regulatory approval for its high oleic soybean product, further demonstrating its commitment to innovation in the agricultural sector. The company continues to drive advancements in plant breeding, offering sustainable solutions to meet growing global food demands. Calyxt Inc's dedication to excellence and cutting-edge research positions it as a key player in the biotechnology industry.
Calyxt Inc is primarily present in the United States.
Calyxt Inc represents values of innovation, sustainability, and ethical practices. The company's corporate philosophy revolves around harnessing the power of cutting-edge gene-editing technology to develop healthier and more sustainable food products. Calyxt is committed to providing consumers with nutritional and environmentally friendly solutions by creating crops with improved characteristics and reduced chemical usage. With a focus on precision breeding techniques, Calyxt aims to revolutionize the agricultural industry and address global challenges such as food security and environmental sustainability. The company's dedication to these values and philosophy drives its mission to create a healthier and more sustainable future.
8 analyytikkoa arvioi tällä hetkellä Calyxt-osaketta: 0 suosittaa ostoa, 5 pitoa ja 3 myyntiä.
Calyxt-osake (CLXT) on listattuna 1 pörssissä, muun muassa: NASDAQ (CLXT).
Calyxt Inc. is a plant breeding company specializing in the research, development, and marketing of innovative plant products. The company was founded in 2010 and is based in Minneapolis, Minnesota. Calyxt focuses on developing plant-based products that offer higher food quality, aiming for sustainable and environmentally friendly food production without the use of artificial chemicals or genetic engineering. They work closely with farmers, retailers, food manufacturers, and consumers. Calyxt has several business areas: 1. Plant gene editing technology: Calyxt has a unique plant gene editing technology that allows the company to influence plant growth, resistance to pests and diseases, and the content of certain nutrients. The company uses a precision method that improves plants without the use of genetic engineering, while still achieving a high degree of precision in gene modification. 2. Soybean and canola cultivation: Calyxt produces and sells high-quality soybean and canola products. These products are resistant to certain herbicides and have higher yields and better quality compared to conventional soybeans and canola. 3. Lentil variety: Calyxt has developed a special lentil variety that is considered a superfood due to its higher nutrient density. This lentil variety is rich in proteins, fiber, and minerals, and contains fewer carbohydrates than traditional lentils. 4. Grain products: Calyxt also offers grain products, specifically wheat and barley, which provide higher yield stability and optimal use of water and fertilizers. The company has launched several products, including a low-acrylamide potato, a high-oil seed, and a healthy lentil variety. Calyxt is also working on developing disease-resistant plants that are less susceptible to diseases and pests. Calyxt aims to promote sustainability in agriculture by developing products that allow farmers to grow more on less land while using less water and fertilizers. Calyxt Inc. presents an alternative to traditional breeding methods. By using safe plant gene editing technology, they can increase the nutritional value of food, reduce the use of pesticides and fertilizers, and lessen the environmental impact of agriculture. Through continuing this work and developing new technologies and products, Calyxt will play an important role in meeting the future demands of the agricultural industry.
Liikevaihtoa ei voida laskea Calyxt:lle tällä hetkellä.
Voittoa ei voida laskea Calyxt:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Calyxt:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Calyxt:lle tällä hetkellä.
Calyxt:n Eulpool-laatuscore on 2/10.
Calyxt:n ISIN on US13173L1070. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Calyxt:n WKN on A2DU9F. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Calyxt:n ticker on CLXT. Tämä pörssinoteeraus käytetään Calyxt-osakkeiden kauppaan pörssissä.
Calyxt osake
Calyxt vertaisryhmä
Calyxt Ticker
Kaikki tunnusluvut ja syvällinen analyysi Calyxt:sta
Meidän osakeanalyysimme Calyxt-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Calyxt:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: